Anna Narezkina

792 total citations
14 papers, 349 citations indexed

About

Anna Narezkina is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Narezkina has authored 14 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Narezkina's work include Chronic Lymphocytic Leukemia Research (2 papers), Cardiac Valve Diseases and Treatments (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Anna Narezkina is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Cardiac Valve Diseases and Treatments (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Anna Narezkina collaborates with scholars based in United States, South Korea and China. Anna Narezkina's co-authors include Anna Marie Skalka, Richard A. Katz, J. Hayashi, Samuel Litwin, Christoph Seeger, Radka Stoyanova, Konstantin D. Taganov, Hari K. Narayan, Alice E. Zemljic‐Harpf and Kirk U. Knowlton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Anna Narezkina

14 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Narezkina United States 9 180 116 95 52 48 14 349
Frédéric Pileur France 6 399 2.2× 72 0.6× 21 0.2× 25 0.5× 41 0.9× 6 443
Jocelyn O. Eidahl United States 9 381 2.1× 42 0.4× 44 0.5× 149 2.9× 136 2.8× 11 447
Kamalpreet Arora United States 7 272 1.5× 37 0.3× 47 0.5× 103 2.0× 33 0.7× 8 402
Kathleen Meyer United States 11 313 1.7× 21 0.2× 219 2.3× 24 0.5× 32 0.7× 23 469
Virginie Boucherit France 10 226 1.3× 24 0.2× 67 0.7× 129 2.5× 58 1.2× 10 462
Luciana Poddighe Italy 5 158 0.9× 45 0.4× 41 0.4× 25 0.5× 16 0.3× 6 393
Jian Dong United States 10 251 1.4× 11 0.1× 142 1.5× 44 0.8× 55 1.1× 16 465
Sharon Tamir United States 11 303 1.7× 17 0.1× 51 0.5× 23 0.4× 112 2.3× 25 524
Edward M. Murray United States 10 89 0.5× 28 0.2× 25 0.3× 40 0.8× 131 2.7× 12 461
Elena Uleri Italy 11 242 1.3× 31 0.3× 39 0.4× 34 0.7× 25 0.5× 15 527

Countries citing papers authored by Anna Narezkina

Since Specialization
Citations

This map shows the geographic impact of Anna Narezkina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Narezkina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Narezkina more than expected).

Fields of papers citing papers by Anna Narezkina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Narezkina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Narezkina. The network helps show where Anna Narezkina may publish in the future.

Co-authorship network of co-authors of Anna Narezkina

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Narezkina. A scholar is included among the top collaborators of Anna Narezkina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Narezkina. Anna Narezkina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Yun, Karen, et al.. (2024). Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome. JCO Precision Oncology. 8(8). e2300265–e2300265. 1 indexed citations
2.
Kim, Paul, et al.. (2024). Regional Strain of Right Ventricle From Computed Tomography Improves Risk Stratification of Right Ventricle Failure. ASAIO Journal. 70(5). 358–364. 1 indexed citations
3.
Narezkina, Anna, Nausheen Akhter, Xiaoxiao Lu, et al.. (2022). Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke. Clinical Lymphoma Myeloma & Leukemia. 22(11). e959–e971. 10 indexed citations
4.
Yang, Jenny, et al.. (2022). Etiology of pulmonary hypertension in multiple myeloma: A case series and literature review. Respiratory Medicine. 206. 107071–107071. 2 indexed citations
5.
Cho, Jae Yeong, et al.. (2021). Prognostic Value of Global Longitudinal Strain in Patients With Heart Failure With Improved Ejection Fraction. JACC Heart Failure. 10(1). 27–37. 29 indexed citations
6.
Yang, Jenny, et al.. (2021). Carfilzomib‐associated pulmonary arterial hypertension in multiple myeloma. Pulmonary Circulation. 11(4). 1–3. 11 indexed citations
7.
Narezkina, Anna, Hari K. Narayan, & Alice E. Zemljic‐Harpf. (2021). Molecular mechanisms of anthracycline cardiovascular toxicity. Clinical Science. 135(10). 1311–1332. 45 indexed citations
8.
Rigolli, Marzia, Davis M. Vigneault, Seth Kligerman, et al.. (2021). Automated cardiac volume assessment and cardiac long- and short-axis imaging plane prediction from electrocardiogram-gated computed tomography volumes enabled by deep learning. European Heart Journal - Digital Health. 2(2). 311–322. 13 indexed citations
9.
10.
Power, John R., Wouter C. Meijers, Charlotte Fenioux, et al.. (2020). Predictors of steroid-refractory immune checkpoint inhibitor associated myocarditis. European Heart Journal. 41(Supplement_2). 2 indexed citations
11.
Peter, Angela K., Dingding Xiong, Anna Narezkina, et al.. (2013). Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy. Journal of Clinical Investigation. 123(12). 5146–5151. 40 indexed citations
12.
Blasius, Amanda L., Adrienne E. Dubin, Matt Petrus, et al.. (2011). Hypermorphic mutation of the voltage-gated sodium channel encoding gene Scn10a causes a dramatic stimulus-dependent neurobehavioral phenotype. Proceedings of the National Academy of Sciences. 108(48). 19413–19418. 35 indexed citations
13.
14.
Narezkina, Anna, Konstantin D. Taganov, Samuel Litwin, et al.. (2004). Genome-Wide Analyses of Avian Sarcoma Virus Integration Sites. Journal of Virology. 78(21). 11656–11663. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédéric Pileur Breakdown of academic impact, for papers by Jocelyn O. Eidahl Breakdown of academic impact, for papers by Kamalpreet Arora Breakdown of academic impact, for papers by Kathleen Meyer Breakdown of academic impact, for papers by Virginie Boucherit Breakdown of academic impact, for papers by Luciana Poddighe Breakdown of academic impact, for papers by Jian Dong Breakdown of academic impact, for papers by Sharon Tamir Breakdown of academic impact, for papers by Edward M. Murray Breakdown of academic impact, for papers by Elena Uleri
Rankless by CCL
2026